Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood.

Abstract

A reliable system for evaluating 5-lipoxygenase (5-LO) pathway inhibitors employing human whole blood stimulated by the calcium ionophore, A-23187, and yeast cell walls (YCW) is described. In developing this system, we have shown that leukotriene B4 (LTB4) and 5-hydroxyeicosatetraenoic acid (5-HETE) can be recovered quantitatively from whole blood, and can be measured with accuracy and a precision (standard deviation) of +/- 12%. Apparent differences in LTB4/5-HETE levels between donors can be minimized by normalizing the LTB4/5-HETE production to neutrophil number. Variability in LTB4/5-HETE production among different donors was reduced by increasing the ionophore concentration. The kinetics of ionophore stimulated product production display a 1-4 min lag which is dependent on ionophore concentration. The lag is removed by pretreatment of blood with 5 micrograms/ml cytochalasin B. Likewise, the kinetics of product formation after stimulation with yeast cell walls demonstrated a lag period, which could be shortened by prior opsonization of the YCW. The amount of LTB4 metabolism to 20-OH-LTB4 and 20-COOH-LTB4 in this system is approximately 20%. Phenidone, nordihydroguaiaretic acid, and nafazatrom, known inhibitors of the 5-LO pathway, display half-maximal inhibition points of 0.4, 1.5, and 9 micrograms/ml, respectively. In summary, we believe that this assay offers a guide for predicting systemic levels of drug needed to be achieved for effective inhibition of cellular LTB4/5-HETE synthesis/release in humans.

Statistics

0200400600'89'92'95'98'01'04'07'10'13'16
Citations per Year

236 Citations

Semantic Scholar estimates that this publication has 236 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Sweeney1987DevelopmentOA, title={Development of a system for evaluating 5-lipoxygenase inhibitors using human whole blood.}, author={F. J. Sweeney and James D. Eskra and Thomas J. Carty}, journal={Prostaglandins, leukotrienes, and medicine}, year={1987}, volume={28 1}, pages={73-93} }